One World Pharma Adds New Leadership as Company Enters Revenue Phase
LAS VEGAS, June 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- One World Pharma Inc. (OWPC), “OWP,” a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce that effective immediately, NBA legend, international entrepreneur and philanthropist Isiah Thomas has been appointed as its CEO and Vice-Chairman of the Board of Directors. Mr. Thomas will replace founder and CEO Craig Ellins who is retiring.
Isiah Thomas, while forever known for his Hall of Fame career as a 12-time NBA All Star, two-time NBA champion, and inclusion as one of the 50 Greatest Players in NBA History, is an accomplished and highly regarded international business executive and investor with a portfolio of companies he has developed via Isiah International Inc. Mr. Thomas has previously served on the Chicago Stock Exchange’s Board of Governors, was a co-founder of the NBA’s Toronto Raptors, Popcorn Indiana, and is a member of the Board of Get-in Chicago, an organization focused on preventing gang violence in Chicago, since 2013.
His business interests include sports and entertainment, real estate, waste management, his cannabis and CBD products company, VESL Oils, and more. Notably, Mr. Thomas has developed a highly successful champagne business with Cheurlin Champagnes, where he has cultivated an excellent relationship with both the grower, employees and the French government. Mr. Thomas now uniquely owns genetics for the grapes produced for the champagne and has perfected an international import/export system for international distribution of the product.
Mr. Thomas inherits the reins of an ascendant international hemp and cannabis company which under Mr. Ellins’ leadership has seen significant development and progress, including the establishment of highly scalable farm and production facilities in Colombia, a portfolio of fully registered elite and government approved genetic strains, and a state sanctioned THC quota.
The Board of Directors is grateful to Mr. Ellins and thanks him for his innovation, dedication, and determination.
“We are elated to welcome Isiah Thomas to the One World Pharma leadership team and to have him continue and expand upon the successes of Craig Ellins,” stated Dr. Kenneth Perego, Executive Chairman of One World Pharma. “Mr. Thomas is the ideal person to lead us in this new phase as we commence commercial sales and revenues, lending to our cause his international business experience, myriad relationships, and commitment to winning.”
“It is truly an honor to work with Mr. Thomas on the One World Pharma opportunity and to leverage his experience in such similar verticals to the benefit of the Company, its shareholders and our indigenous partners in Colombia,” added Brian Moore, President, One World Pharma.
“I am honored to join One World Pharma and its excellent team. It is a company that is leading the way in innovation in the hemp and cannabis industry,” said Isiah Thomas, CEO and Vice-Chairman. “The company’s deep commitment to excellence in their products and for its customers positions us well to continue to grow as an international leader in the industry. Its recognition for its humanitarian efforts validates its mission as a socially conscious company in a true partnership with the indigenous people.”
One World Pharma Investor Relations & Financial Media
Toll Free: (888) 216-3595
Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.